BlackRock Capital Allocation Term Trust (NYSE:BCAT - Get Free Report) hit a new 52-week high during trading on Tuesday . The company traded as high as $16.20 and last traded at $16.1650, with a volume of 150695 shares traded. The stock had previously closed at $16.08.
BlackRock Capital Allocation Term Trust Stock Up 0.2%
The company has a 50 day moving average of $15.76 and a two-hundred day moving average of $15.24.
BlackRock Capital Allocation Term Trust Announces Dividend
The business also recently disclosed a monthly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Tuesday, September 15th will be issued a dividend of $0.2542 per share. This represents a c) annualized dividend and a yield of 18.9%. The ex-dividend date of this dividend is Tuesday, September 15th.
Hedge Funds Weigh In On BlackRock Capital Allocation Term Trust
A number of hedge funds have recently made changes to their positions in the company. NewEdge Advisors LLC boosted its stake in shares of BlackRock Capital Allocation Term Trust by 4.7% in the third quarter. NewEdge Advisors LLC now owns 16,100 shares of the company's stock worth $238,000 after acquiring an additional 724 shares during the last quarter. N.E.W. Advisory Services LLC boosted its stake in BlackRock Capital Allocation Term Trust by 100.0% during the 4th quarter. N.E.W. Advisory Services LLC now owns 2,400 shares of the company's stock worth $34,000 after purchasing an additional 1,200 shares during the last quarter. Quantinno Capital Management LP grew its stake in BlackRock Capital Allocation Term Trust by 3.3% during the 1st quarter. Quantinno Capital Management LP now owns 41,232 shares of the company's stock valued at $583,000 after acquiring an additional 1,324 shares in the last quarter. Walkner Condon Financial Advisors LLC grew its position in shares of BlackRock Capital Allocation Term Trust by 8.6% in the first quarter. Walkner Condon Financial Advisors LLC now owns 17,613 shares of the company's stock valued at $249,000 after purchasing an additional 1,400 shares in the last quarter. Finally, Geneos Wealth Management Inc. lifted its position in BlackRock Capital Allocation Term Trust by 341.7% during the second quarter. Geneos Wealth Management Inc. now owns 2,045 shares of the company's stock worth $31,000 after buying an additional 1,582 shares in the last quarter. Institutional investors and hedge funds own 36.12% of the company's stock.
BlackRock Capital Allocation Term Trust Company Profile
(
Get Free Report)
BlackRock Capital Allocation Term Trust NYSE: BCAT is a closed-end, diversified management investment company organized as a term trust. The fund's primary objective is to deliver high current income and total return by investing across a broad range of credit and equity markets. BCAT seeks to achieve this objective through a portfolio of corporate debt securities, floating-rate loans, convertible securities, common and preferred equity, and asset-backed securities.
BCAT employs an actively managed, multi-sector credit approach that spans investment-grade and below-investment-grade bonds, senior secured loans and structured credit.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider BlackRock Capital Allocation Term Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BlackRock Capital Allocation Term Trust wasn't on the list.
While BlackRock Capital Allocation Term Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
